Antisoma
London, England, United Kingdom
About Antisoma
Antisoma is a biotechnology company specialising in the development of novel drugs for the treatment of cancer. It acquires promising early-stage drug candidates from academic and commercial institutions around the world, to manage the development of these drugs through preclinical testing and clinical trials, and to bring them to the market.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Website: antisoma.com
Social Profiles
Canonical: https://fsome.com/organization/antisoma-2526237 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.